Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical UIse.
暂无分享,去创建一个
R. Kannan | H. Regunath | C. Rojas-Moreno | A. Upendran | S. Whitt | D. Ritter | D. Dandachi | D. Shyu | J. Dorroh | C. Holtmeyer | Hariharan Regunath
[1] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[2] Xiancang Ma,et al. The duration of viral shedding of discharged patients with severe COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] Kwok-Hung Chan,et al. Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in SARS Patients by Enzyme-Linked Immunosorbent Assay , 2004, Journal of Clinical Microbiology.
[4] F. Yu,et al. Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset , 2020, European Respiratory Journal.
[5] Susanne Pfefferle,et al. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[6] Francesco Mojoli,et al. Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department , 2020, Journal of medical virology.
[7] T. Henry,et al. Chest Computed Tomography for Detection of Coronavirus Disease 2019 (COVID-19): Don't Rush the Science , 2020, Annals of Internal Medicine.
[8] A. Caliendo,et al. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[10] Annals Clinical Decision Making: Using a Diagnostic Test , 2020, Annals of Internal Medicine.
[11] Jincun Zhao,et al. T cell-mediated immune response to respiratory coronaviruses , 2014, Immunologic Research.
[12] M. Müller,et al. Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience , 2018, Antiviral therapy.
[13] P. Woo,et al. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus , 2015, Emerging Microbes & Infections.
[14] G. Gore,et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction , 2017, Annals of Internal Medicine.
[15] J. Mascola,et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial , 2008, Vaccine.
[16] S. Blomqvist,et al. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[17] Anita Patel,et al. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020 , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] C. Sheridan. Fast, portable tests come online to curb coronavirus pandemic , 2020, Nature Biotechnology.
[19] R. Lu,et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.
[20] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[21] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[22] F. Hayden,et al. Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Feasibility of Using Convalescent Plasma Immunotherapy for Mers-cov Infection, Saudi Arabia , 2022 .
[23] Rui Liu,et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 , 2020, Clinica Chimica Acta.
[24] Yiu Chung Lau,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.
[25] Kwok-Hung Chan,et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens , 2020, Journal of Clinical Microbiology.
[26] Q. Tao,et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.
[27] Tara C Smith,et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19 , 2020, mBio.
[28] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[29] C. Cunningham-Rundles,et al. A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, Nature Medicine.
[30] Y. Yazdanpanah,et al. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.
[31] Shaoqiang Li,et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.
[32] S. H. Kim,et al. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[33] Jonathan E. Schmitz,et al. Laboratory Diagnosis of COVID-19: Current Issues and Challenges , 2020, Journal of Clinical Microbiology.
[34] J. Tanne. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients , 2020, BMJ.
[35] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[36] Bingliang Zeng,et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? , 2020, European Journal of Radiology.
[37] Zuowei Ni,et al. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection , 2020, Journal of Microbiology, Immunology and Infection.
[38] Keith R. Jerome,et al. Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit , 2020, Journal of Clinical Microbiology.
[39] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[40] Shangen Zheng,et al. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2 , 2020, Journal of Clinical Microbiology.
[41] R. Guimarães,et al. Principles and applications of polymerase chain reaction in medical diagnostic fields: a review , 2009, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[42] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[43] Lai St. Treatment of severe acute respiratory syndrome , 2005 .
[44] A. Petherick. Developing antibody tests for SARS-CoV-2 , 2020, The Lancet.
[45] Shibo Jiang,et al. Recent advances in the detection of respiratory virus infection in humans , 2020, Journal of medical virology.
[46] Malik Peiris,et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia , 2020, Clinical chemistry.
[47] Yan Peng,et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.
[48] Mario Plebani,et al. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) , 2020, Clinical chemistry and laboratory medicine.
[49] J. Guarner,et al. Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. , 2020, JAMA.
[50] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[51] J. Papenburg,et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis , 2015, Journal of Clinical Microbiology.
[52] Christian Drosten,et al. Serological assays for emerging coronaviruses: Challenges and pitfalls , 2014, Virus Research.
[53] Wei Zhang,et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.
[54] Daniel M Altmann,et al. What policy makers need to know about COVID-19 protective immunity , 2020, The Lancet.
[55] Lei Liu,et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.
[56] Yuan Shi,et al. Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.
[57] W. Lim,et al. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.
[58] Sheng Zhang,et al. False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence , 2020, Journal of medical virology.
[59] T. Ganiats,et al. Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis , 2012, BMC Research Notes.
[60] M. Franchini,et al. Operational protocol for donation of anti‐COVID‐19 convalescent plasma in Italy , 2020, Vox sanguinis.
[61] G. Agrawal,et al. Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes. , 2007, Current genomics.
[62] Yiyan Song,et al. Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 , 2020, Journal of medical virology.
[63] Qi Jin,et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] Michael Libman,et al. Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2 , 2020, Annals of Internal Medicine.
[65] Yicheng Fang,et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.
[66] Constantine A Raptis,et al. A role for CT in COVID-19? What data really tell us so far , 2020, The Lancet.
[67] Y. Teo,et al. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review , 2020, Journal of clinical medicine.
[68] L. May,et al. Better Tests, Better Care: Improved Diagnostics for Infectious Diseases , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[69] Bernhard Liebl,et al. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[70] E. Petersen,et al. SARS-CoV-2 shedding and infectivity , 2020, The Lancet.